Latest filing published 03 Oct 2016 for IMS Health Holdings, Inc..
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Karen L. Katen has filed trades across 5 companies (mainly through SEC (Form 4)), most often in L3harris Technologies, Inc. /DE/, Pfizer Inc and SXC Health Solutions Corp. The record holds 38 filings, for trades running from 23 February 2006 to 3 October 2016.
Both buying and selling appear: 2 purchases worth €170k, against 13 sales worth €4.1M. The net balance comes to €3.9M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 7 share grants and 14 option exercises.
On 3 October 2016 came the latest disclosure, a transaction in IMS Health Holdings, Inc. The clock since the last published purchase (12 March 2013) now reads 4,973 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 32 declarations